Hypothalamic syndrome (HS) is a rare disorder caused by disease-related and/or treatment-
related injury to the hypothalamus, most commonly associated with rare, non-cancerous …

The development of hypothalamic obesity (HO) following craniopharyngioma (CP) and other
suprasellar tumors leads to reduced patient quality of life. No treatment algorithms are …

Craniopharyngioma and hypothalamic injury: latest insights i... : Current Opinion in
Endocrinology, Diabetes and Obesity Craniopharyngioma and hypothalamic injury: latest …

Objective Hypothalamic syndrome (HS) in childhood is a rare condition. Its epidemiology is
not well known because incidence and prevalence are related to very rare underlying …

Context Unlike homozygous variants, the implication of heterozygous variants on the leptin–
melanocortin pathway in severe obesity has not been established. Objective To describe the …

Background Craniopharyngiomas are morbid tumors that significantly reduce patients'
quality of life (QoL). The lifelong burden of endocrine, visual, hypothalamic, and limbic …

Craniopharyngioma (CP) is a benign tumor with a high rate of obesity and frequent
recurrence. Moreover, the role of leptin/leptin receptors axis in obesity and the prognosis of …

Purpose This report is a review of findings on the diagnosis, treatment, clinical course, follow-
up, and prognosis of craniopharyngioma patients with special regard to clinical trials and …

Objective Children with suprasellar brain damage are at risk of hypothalamic dysfunction
(HD). HD may lead to decreased resting energy expenditure (REE). Decreased REE …

Introduction Hypothalamic obesity (HO) in children has severe health consequences.
Lifestyle interventions are mostly insufficient and currently no drug treatment is approved for …